Teleflex Incorporated (NYSE:TFX) Shares Sold by Johnson Investment Counsel Inc.

Johnson Investment Counsel Inc. lessened its position in Teleflex Incorporated (NYSE:TFX) by 2.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,888 shares of the medical technology company’s stock after selling 201 shares during the period. Johnson Investment Counsel Inc.’s holdings in Teleflex were worth $1,226,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Apollon Wealth Management LLC raised its position in shares of Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after buying an additional 55 shares during the last quarter. SRS Capital Advisors Inc. raised its position in shares of Teleflex by 0.3% in the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after buying an additional 60 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. grew its holdings in Teleflex by 4.5% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after purchasing an additional 66 shares during the period. HighTower Advisors LLC grew its holdings in Teleflex by 1.7% in the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares during the period. Finally, Huntington National Bank grew its holdings in Teleflex by 32.5% in the third quarter. Huntington National Bank now owns 310 shares of the medical technology company’s stock valued at $77,000 after purchasing an additional 76 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on TFX shares. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. Citizens Jmp downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Truist Financial lowered their target price on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a report on Monday, March 3rd. Finally, Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $182.63.

Teleflex Price Performance

Teleflex stock opened at $139.25 on Wednesday. Teleflex Incorporated has a 52-week low of $128.55 and a 52-week high of $249.90. The firm has a fifty day moving average of $169.58 and a 200-day moving average of $199.60. The firm has a market capitalization of $6.46 billion, a P/E ratio of 27.68, a PEG ratio of 1.73 and a beta of 1.21. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date is Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.